ClinicalTrials.gg
CompletedNCT06770114Updated Dec 1, 2025

Clinical Study to Investigate a New Mouthwash in Reducing Plaque and Helping Prevent Gum Problems on Dental Implants Over a 6-month Period of Product Use

A Phase 3 interventional study of Cetylpyridinium Chloride, Zinc Lactate and Hyaluronic Acid Mouthwash and PhosFlur Mouthwash in Gingivitis, sponsored by Colgate Palmolive. Completed at 1 site in Italy. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-01.

Sponsored by Colgate Palmolive · Phase 3, Interventional, and Prevention

From the registry’s dates

  • Primary completion was May 2022, 4 years 6 months ago, and no results have been posted to the registry.
  • Registered 3 years 2 months after the study started (first participant enrolled Oct 2021, registered Jan 2025).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 44 studies in Gingivitis by Colgate Palmolive — 8 open to participants now, 9 under way, 5 of them phase 3. Gingivitis · Colgate Palmolive.

Enrollment
34th of 44
80 · median 94
Started
2021
the only one that year
Phase 3
25 of 44
4 open now
Registered
27th of 44
by date

Among the 44 studies in Gingivitis by Colgate Palmolive, this one is the 34th largest by enrollment, is the only one that started in 2021, is one of 25 in phase 3, and was the 27th registered.

Gingivitis

631 studies on the registry are indexed under Gingivitis; 107 are open to participants now.

Browse Gingivitis studies →

Open to participants now

8 of the 44 studies in Gingivitis by Colgate Palmolive are open now, in 5 countries. Recruiting first, the newest first:

3 more — sign in →

By country, each count listing its studies:

All 8 open studies →

Who these studies take

Of the 53 Gingivitis studies recruiting now, 15 (28%) set no upper age limit and 36 (68%) stop at 75 or younger; 11 take children under 18; 35 take healthy volunteers.

This study: 18 Years to 70 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 44 studies in Gingivitis by Colgate Palmolive, or all of them as a file.
02

Study summary

The objective of this six-month clinical research study is to evaluate the clinical efficacy of a new mouthwash on helping prevent gum problems (gingival index scores ) in adults as compared to a control mouthwash.

03

Conditions studied

  • Gingivitis

Browse trials for

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Availability for the six-month duration of the clinical research study.
  • Good general health.
  • Minimum of two dental implants (2 different quadrants ), each implant must have a restoration.
  • Initial mucositis index of at least 1 .0 as determined by the use of the Mombelli Modified Gingival Index.
  • Initial plaque index of at least 1 .5 as determined by the use of the Mombelli Modified Plaque Index.
  • Signed Form.

Exclusion criteria

Exclusion Criteria:

  • Presence of orthodontic bands.
  • Tumor (s ) of the soft or hard tissues of the oral cavity.
  • Advanced periodontal disease (purulent exudate, tooth mobility, and /or extensive loss of periodontal attachment or alveolar bone ) or peri-implantitis.
  • Five or more carious lesions requiring immediate restorative treatment.
  • Antibiotic use any time during the one-month period prior to entry into the study.
  • Participation in any other clinical study or test panel within the one month prior to entry into the study.
  • Dental prophylaxis during the past two weeks prior to baseline examinations.
  • History of allergies to oral care /personal care consumer products or their ingredients.
  • On any prescription medicines that might interfere with the study outcome.
  • An existing medical condition that prohibits eating or drinking for periods up to 4 hours.
  • History of alcohol or drug abuse.
  • Self-reported pregnant or lactating subjects
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Phase 3
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
80 participants (actual)

Study arms

  • Experimental
    New Mouthwash containing CPC, Zinc and Hyaluronic acid

    After brushing in the morning and in the evening, 20 ml of mouthwash shall be used for each rinsing, 2 times daily (morning and evening ) for 30 seconds each time. No further rinsing with water shall be occurred after spilt out and after each mouthwash rising. Each qualified subject will follow this specific application for 6 months

    Drug: Cetylpyridinium Chloride, Zinc Lactate and Hyaluronic Acid Mouthwash

  • Active comparator
    Fluoride Mouthwash

    After brushing in the morning, 10 ml of mouthwash shall be used for each rinsing, 1 time daily (morning ) for 60 seconds each time. No further rinsing with water shall be occurred after spilt out and after each mouthwash rising. Each qualified subject will follow this specific application for 6 months.

    Drug: PhosFlur Mouthwash

Interventions

  • DrugCetylpyridinium Chloride, Zinc Lactate and Hyaluronic Acid Mouthwash

    Drug pages: Cetylpyridinium · Zinc lactate · Hyaluronic Acid

    0 .075 % cetylpyridinium chloride and 0 .28 % zinc lactate

  • DrugPhosFlur Mouthwash

    0 .044 % sodium fluoride

06

What researchers measure

Primary outcomes

  1. Mombelli Modified Gingival Index

    Initial mucositis index of at least 1.0 as determined by the use of the Mombelli Modified Gingival

    Time frame: baseline

  2. Mombelli Modified Gingival Index

    Initial mucositis index of at least 1.0 as determined by the use of the Mombelli Modified Gingival

    Time frame: three month

  3. Mombelli Modified Gingival Index

    Initial mucositis index of at least 1.0 as determined by the use of the Mombelli Modified Gingival

    Time frame: six month

  4. Mombelli Modified Plaque Index

    Initial plaque index of at least 1 .5 as determined by the use of the Mombelli Modified Plaque

    Time frame: baseline

  5. Mombelli Modified Plaque Index

    Initial plaque index of at least 1 .5 as determined by the use of the Mombelli Modified Plaque

    Time frame: three month

  6. Mombelli Modified Plaque Index

    Initial plaque index of at least 1 .5 as determined by the use of the Mombelli Modified Plaque

    Time frame: six month

07

Study locations

1 site
  • Clinica Odontoiatrica Montesani
    Roma, Rome 00187, Italy
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2021 to primary completion in May 2022, 6 months.

Of 23 industry-sponsored phase 3 interventional studies under Gingivitis, half reached primary completion within 3 months of starting (the median), counting those still running; a quarter within 2 and three quarters within 6. This study's 6 months is above that.

Counting every sponsor, half of 35 studies reached it within 3 months; a quarter within 2 and three quarters within 6.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 7, 2025
First posted
Jan 13, 2025
StartActual
Oct 18, 2021
Primary completionActual
May 9, 2022
CompletionActual
May 9, 2022
Last update
Dec 1, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 1, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06770114
Lead sponsor
Colgate Palmolive
Responsible party
Sponsor
First posted
Jan 13, 2025
Start date
Oct 18, 2021
Primary completion
May 9, 2022
Completion
May 9, 2022
Last update
Dec 1, 2025

Study contacts

Luigi Montesani, DDS
principal investigator · University of Rome

Oversight

Data monitoring committee
No
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Cetylpyridinium · Zinc lactate · Hyaluronic Acid

Start the discussion